BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kogire M, Inoue K, Higashide S, Takaori K, Echigo Y, Gu YJ, Sumi S, Uchida K, Imamura M. Protective effects of endothelin-1 on acute pancreatitis in rats. Dig Dis Sci. 1995;40:1207-1212. [PMID: 7540127 DOI: 10.1007/bf02065525] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Andrzejewska A, Dlugosz JW, Augustynowicz A. Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats. World J Gastroenterol 2005; 11(8): 1115-1121 [PMID: 15754391 DOI: 10.3748/wjg.v11.i8.1115] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
2 Chen YD, Zhou ZG, Wang Z, Gao HK, Yan WW, Wang C, Zhao GP, Peng XH. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats. World J Gastroenterol 2005; 11(4): 538-544 [PMID: 15641142 DOI: 10.3748/wjg.v11.i4.538] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
3 Martignoni ME, Ceyhan GO, Ayuni E, Kondo Y, Zimmermann A, Büchler MW, Friess H. Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis. Langenbecks Arch Surg. 2004;389:184-192. [PMID: 15127205 DOI: 10.1007/s00423-004-0461-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
4 Plusczyk T, Bersal B, Menger MD, Feifel G. Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation. Dig Dis Sci. 2001;46:1343-1351. [PMID: 11414314 DOI: 10.1023/a:1010640002323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fiedler F, Ayasse D, Rohmeiss P, Gretz N, Rehbein C, Keim V. The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats. Int J Pancreatol. 1999;26:147-154. [PMID: 10732291 DOI: 10.1385/ijgc:26:3:147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
6 Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut 2000;46:390-4. [PMID: 10673302 DOI: 10.1136/gut.46.3.390] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.3] [Reference Citation Analysis]
7 Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Ann Surg. 1998;228:670-675. [PMID: 9833805 DOI: 10.1097/00000658-199811000-00006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]